The Worldwide Epidemiology of Type 2 Diabetes Mellitus--present and Future Perspectives

Overview

Journal Nat Rev Endocrinol

Specialty Endocrinology

Date 2011 Nov 9

PMID 22064493

Citations 838

Authors

Lei Chen

Dianna J Magliano

Paul Z Zimmet

Affiliations

Soon will be listed here.

Abstract

Over the past three decades, the number of people with diabetes mellitus has more than doubled globally, making it one of the most important public health challenges to all nations. Type 2 diabetes mellitus (T2DM) and prediabetes are increasingly observed among children, adolescents and younger adults. The causes of the epidemic of T2DM are embedded in a very complex group of genetic and epigenetic systems interacting within an equally complex societal framework that determines behavior and environmental influences. This complexity is reflected in the diverse topics discussed in this Review. In the past few years considerable emphasis has been placed on the effect of the intrauterine environment in the epidemic of T2DM, particularly in the early onset of T2DM and obesity. Prevention of T2DM is a 'whole-of-life' task and requires an integrated approach operating from the origin of the disease. Future research is necessary to better understand the potential role of remaining factors, such as genetic predisposition and maternal environment, to help shape prevention programs. The potential effect on global diabetes surveillance of using HbA(1c) rather than glucose values in the diagnosis of T2DM is also discussed.

Citing Articles

Controlled induction of type 2 diabetes in mice using high fat diet and osmotic-mini pump infused streptozotocin.

Attrill E, Scharapow O, Perera S, Mayne S, Sumargo N, Ross R Sci Rep. 2025; 15(1):8812.

PMID: 40087321 DOI: 10.1038/s41598-025-89162-2.

Excess of rare noncoding variants in several type 2 diabetes candidate genes among Asian Indian families.

Rout M, Ramu D, Mariana M, Koshy T, Venkatesan V, Lopez-Alvarenga J Commun Med (Lond). 2025; 5(1):47.

PMID: 39987249 PMC: 11846969. DOI: 10.1038/s43856-025-00750-9.

Association between atherogenic index of plasma and type 2 diabetic complications: a cross-sectional study.

Zhang Y, Yang X, Wan Q Front Endocrinol (Lausanne). 2025; 16:1537303.

PMID: 39968299 PMC: 11832369. DOI: 10.3389/fendo.2025.1537303.

Deciphering the Topology of Sitagliptin Using an Integrated Approach.

Mathew R, Thomas B ACS Omega. 2025; 10(2):2289-2295.

PMID: 39866596 PMC: 11755177. DOI: 10.1021/acsomega.4c09930.

The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus.

Kim J, Lee J, Cha G, Yoon J Biomimetics (Basel). 2025; 10(1).

PMID: 39851765 PMC: 11760843. DOI: 10.3390/biomimetics10010049.

References

Dabelea D, Bell R, DAgostino Jr R, Imperatore G, Johansen J, Linder B . Incidence of diabetes in youth in the United States. JAMA. 2007; 297(24):2716-24. DOI: 10.1001/jama.297.24.2716. View

Selvin E, Zhu H, Brancati F . Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care. 2009; 32(5):828-33. PMC: 2671106. DOI: 10.2337/dc08-1699. View

Saaristo T, Moilanen L, Korpi-Hyovalti E, Vanhala M, Saltevo J, Niskanen L . Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care. 2010; 33(10):2146-51. PMC: 2945150. DOI: 10.2337/dc10-0410. View

Danaei G, Finucane M, Lu Y, Singh G, Cowan M, Paciorek C . National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011; 378(9785):31-40. DOI: 10.1016/S0140-6736(11)60679-X. View

Lawrence J, Mayer-Davis E, Reynolds K, Beyer J, Pettitt D, DAgostino Jr R . Diabetes in Hispanic American youth: prevalence, incidence, demographics, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009; 32 Suppl 2:S123-32. PMC: 2647689. DOI: 10.2337/dc09-S204. View

Lindstrom J, Peltonen M, Eriksson J, Aunola S, Hamalainen H, Ilanne-Parikka P . Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care. 2008; 31(5):857-62. DOI: 10.2337/dc07-2162. View

Arnlov J, Sundstrom J, Ingelsson E, Lind L . Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care. 2010; 34(1):61-5. PMC: 3005442. DOI: 10.2337/dc10-0955. View

Salmi I, Hoy W, Kondalsamy-Chennakesavan S, Wang Z, Gobe G, Barr E . Disorders of glucose regulation in adults and birth weight: results from the Australian Diabetes, Obesity and Lifestyle (AUSDIAB) Study. Diabetes Care. 2007; 31(1):159-64. DOI: 10.2337/dc07-1170. View

. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32(7):1327-34. PMC: 2699715. DOI: 10.2337/dc09-9033. View

10.

Crume T, Ogden L, West N, Vehik K, Scherzinger A, Daniels S . Association of exposure to diabetes in utero with adiposity and fat distribution in a multiethnic population of youth: the Exploring Perinatal Outcomes among Children (EPOCH) Study. Diabetologia. 2010; 54(1):87-92. PMC: 3027214. DOI: 10.1007/s00125-010-1925-3. View

11.

Bavdekar A, Yajnik C, Fall C, Bapat S, Pandit A, Deshpande V . Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both?. Diabetes. 1999; 48(12):2422-9. DOI: 10.2337/diabetes.48.12.2422. View

12.

Zimmet P, Alberti K, Shaw J . Global and societal implications of the diabetes epidemic. Nature. 2001; 414(6865):782-7. DOI: 10.1038/414782a. View

13.

Schulze M, Weikert C, Pischon T, Bergmann M, Al-Hasani H, Schleicher E . Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study. Diabetes Care. 2009; 32(11):2116-9. PMC: 2768223. DOI: 10.2337/dc09-0197. View

14.

Dabelea D, Snell-Bergeon J, Hartsfield C, Bischoff K, Hamman R, McDuffie R . Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care. 2005; 28(3):579-84. DOI: 10.2337/diacare.28.3.579. View

15.

Meigs J, Wilson P, Fox C, Vasan R, Nathan D, Sullivan L . Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006; 91(8):2906-12. DOI: 10.1210/jc.2006-0594. View

16.

Lango H, Palmer C, Morris A, Zeggini E, Hattersley A, McCarthy M . Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes. 2008; 57(11):3129-35. PMC: 2570411. DOI: 10.2337/db08-0504. View

17.

Craig M, Femia G, Broyda V, Lloyd M, Howard N . Type 2 diabetes in Indigenous and non-Indigenous children and adolescents in New South Wales. Med J Aust. 2007; 186(10):497-9. DOI: 10.5694/j.1326-5377.2007.tb01021.x. View

18.

Alonso-Magdalena P, Quesada I, Nadal A . Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol. 2011; 7(6):346-53. DOI: 10.1038/nrendo.2011.56. View

19.

Grant R, Hivert M, Pandiscio J, Florez J, Nathan D, Meigs J . The clinical application of genetic testing in type 2 diabetes: a patient and physician survey. Diabetologia. 2009; 52(11):2299-2305. PMC: 3829642. DOI: 10.1007/s00125-009-1512-7. View

20.

Lawrence J, Contreras R, Chen W, Sacks D . Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care. 2008; 31(5):899-904. DOI: 10.2337/dc07-2345. View